Guerra Advisors’s Novo Nordisk NVO Stock Holding History

Guerra Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$25K	Buy	+450	New	+$26.3K	0.01%	203

Other funds holding NVO

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Guerra Advisors's NVO Position: Q3 2025 in Review

Guerra Advisors opened a new position in Novo Nordisk (NVO) in Q3 2025: 450 shares worth $25K. The stake represents 0.01% of the portfolio and ranks #203 among its holdings.

1,396 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

Guerra Advisors held 450 shares of Novo Nordisk worth $25K as of Q3 2025.
Novo Nordisk was a new Guerra Advisors position in Q3 2025.
Novo Nordisk made up 0.01% of Guerra Advisors's portfolio in Q3 2025, its #203 holding.
1,396 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Guerra Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.